Africa Climate-Sensitive Disease Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Disease, Test, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Africa · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$53.4 MnPlaceholder estimate
Estimate 2025$57.9 Mn1.7% of the global market
Projected 2034$120.7 Mn 108.4%Adds $62.8 Mn over 9 forecast years
CAGR 2025–20348.5%Faster than 31% of 173 Medical Devices markets here
Key players5
Africa is 1.69% of the global market.
Among regions, the largest is North America at $1.74 Bn.
Fastest growing: Africa (this report) at 8.5% a year.
Africa ranks 6th of 6 by size among regions.
Market size projection
Africa
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$62.8 Mn total, 2026–2034
Year-by-year market size, 2024–2034
Climate-Sensitive Disease Diagnostics Market market size by year, Africa
Year
Market size
Change that year
Since 2025
2024 (estimate)
$53.4 Mn
—
—
2025 (base)
$57.9 Mn
+$4.5 Mn
—
2026 (forecast)
$62.8 Mn
+$4.9 Mn
+8.5%
2027 (forecast)
$68.2 Mn
+$5.3 Mn
+17.7%
2028 (forecast)
$74.0 Mn
+$5.8 Mn
+27.7%
2029 (forecast)
$80.3 Mn
+$6.3 Mn
+38.6%
2030 (forecast)
$87.1 Mn
+$6.8 Mn
+50.4%
2031 (forecast)
$94.5 Mn
+$7.4 Mn
+63.1%
2032 (forecast)
$102.5 Mn
+$8.0 Mn
+77%
2033 (forecast)
$111.2 Mn
+$8.7 Mn
+92.1%
2034 (forecast)
$120.7 Mn
+$9.5 Mn
+108.4%
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Africa Climate-Sensitive Disease Diagnostics Market Analysis Executive Summary
Climate-sensitive disease diagnostics detect illnesses spreading with climate change, such as dengue, malaria, cholera and heat illness.
Key segments of the climate-Sensitive Disease Diagnostics market include disease (Dengue, Malaria and Cholera) and test (Rapid Tests and Molecular Tests).
Africa Climate-Sensitive Disease Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Africa Climate-Sensitive Disease Diagnostics Market Dynamics
Market Growth Drivers
More heatwaves, air pollution, floods and the spread of climate-sensitive diseases are driving the climate-Sensitive Disease Diagnostics market. Health systems are under pressure to cut their own emissions.
Opportunity
Early warning systems, greener hospitals and climate-resilient supply chains give the climate-Sensitive Disease Diagnostics market strong room to grow.
Market Restraints
Limited dedicated funding, unclear responsibility between agencies and lack of local data hold back the climate-Sensitive Disease Diagnostics market.
Competitive Landscape for Climate-Sensitive Disease Diagnostics Market in Africa
The climate-Sensitive Disease Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Climate-Sensitive Disease Diagnostics Market in Africa
Climate-Sensitive Disease Diagnostics in Africa: rules and payment
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)[2], PPB (Kenya)[3] and SAHPRA (South Africa)[4]. How care is paid for in some of these countries: universal health insurance (Egypt)[5], the SHA (Kenya)[6] and planned National Health Insurance (South Africa)[7].
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how climate-Sensitive Disease Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Disease
4.2 By Test
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Abbott Laboratories
7.2 SD Biosensor
7.3 bioMerieux
7.4 QIAGEN
7.5 Molbio Diagnostics
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The climate-Sensitive Disease Diagnostics market can be segmented based on various criteria, including disease and test. Here's a breakdown of the market segmentation
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
How big is the Climate-Sensitive Disease Diagnostics market in Africa?
Placeholder estimate: about $57.9 Mn in 2025, rising to about $120.7 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Climate-Sensitive Disease Diagnostics market in Africa growing?
Placeholder estimate: about 8.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Climate-Sensitive Disease Diagnostics market report cover?
The report splits the market by disease (Dengue, Malaria, Cholera, Leptospirosis and more) and test (Rapid Tests, Molecular Tests).
Who are the key players in the Climate-Sensitive Disease Diagnostics market?
Key players include Abbott Laboratories, SD Biosensor, bioMérieux SA, Qiagen N.V. and Molbio Diagnostics.
What is driving the Climate-Sensitive Disease Diagnostics market?
More heatwaves, air pollution, floods and the spread of climate-sensitive diseases are driving the climate-Sensitive Disease Diagnostics market. Health systems are under pressure to cut their own emissions.
Who regulates Climate-Sensitive Disease Diagnostics in Africa?
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How much research is published on Climate-Sensitive Disease Diagnostics?
PubMed lists 16 papers on Climate-Sensitive Disease Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.